Even in cytokine-secreting tumours other factors may be involved in the development of cachexia, particularly in the erosion of skeletal muscle mass. In the present study, the production of PIF has been determined in a human melanoma cell line, G361. This tumour has been reported to induce severe cachexia in tumour-bearing nude mice and this has been correlated with the expression of LIF (Mori et al, 1991) . In addition, biosynthetic labelling studies have been performed to determine if human PIF contains the same number and size of oligosaccharide chains as previously reported in the mouse as well as the same linking to the polypeptide core. ) were purchased from Amersham International (Bucks, UK). Tissue culture medium and fetal bovine serum (FBS) were from Life Technologies Inc (Paisley, UK). Peptide N-glycosidase F (PNGase F) and endo-α-N-acetylgalactosaminidase (O-glycosidase) were obtained from Oxford Glycosystems Ltd (Oxford, UK). Pure strain NMRI mice were obtained from our own inbred colony and were fed a rat and mouse breeding diet (Special Diet Services, Wiltham, UK). Monoclonal antibody was concentrated from the tissue culture supernatant of a hybridoma using a protein A-Sepharose column as described (Todorov et al, 1996b) . The human melanoma cell line, G361, was obtained from the European Collection of Cell Cultures (Porton Down, Wilts, UK). Affi-Gel Hz was purchased from Bio-Rad (Hemel Hempstead, UK).
MATERIALS AND METHODS

Materials
Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361)
Cell culture and radiolabelling procedures G361 cells were maintained in McCoys 5a medium supplemented with 2 mM glutamine and 10% FBS under an atmosphere of 5% carbon dioxide (CO 2 ) in air. Cells were plated in McCoys 5a medium containing Na 2 35 SO 4 (1 µCi ml -1 ) and [ 3 H]glucosamine (2 µCi ml -1 ) and allowed to grow for 48 h at 37°C under an atmosphere of 5% CO 2 in air. Cells were removed from the substratum with trypsin-EDTA and sedimented by low speed centrifugation (1500 rpm for 5 min on a bench-top centrifuge) followed by washing in phosphate-buffered saline (PBS). The cell pellet was resuspended in 1 ml of 10 mM Tris-HCl (hydrochloric acid), pH 8.0, containing 0.5 mM phenylmethylsulphonyl fluoride (PMSF), 0.5 mM EGTA and 1 mM dithiothreitol, and dissociated using an ultrasonic oscillator. Debris was removed by centrifugation (15 000 rpm for 20 min); solid ammonium sulphate (80% w/v) was added to the supernatant and the mixture was stored overnight at 4°C. The precipitated proteins were collected by Figure 1 Immunoblot of PIF affinity purified from G361 (lane 1) and MAC16 (lane 2) cells detected using monoclonal antibody, which had been biotinylated using the ECL protein biotinylation module (Amersham UK). Samples were electrophoresed on 15% sodium dodecyl sulphate polyacrylamide gels, transferred to nitrocellulose membranes blocked with 5% Marvel in 0.15% Tween-20 in PBS. Filters were washed and incubated for 1 h with 10 µg ml -1 biotinylated antibody. After further washing, filters were incubated for a further 1 h with streptavidin-horseradish peroxidase conjugate (Amersham) and bands were detected with an emission chemiluminescence (ECL) system in 100 mM phosphate-citrate, pH 6.0. The enzyme was free of protease and contaminating glycosidases. Treatment with the incubation buffers alone had no effect on the elution position of the M r 24 000 material centrifugation and the pellet resuspended in the sonicating buffer. Salt was removed by ultrafiltration with an Amicon filtration cell containing a membrane filter with a molecular weight cut-off of 10 000 against the same solution. The concentrated sample was loaded onto an affinity column containing mouse monoclonal antibody coupled to Affi-Gel Hz (Todorov et al, 1996b ) equilibrated with 10 mM Tris-HCl, pH 8.0 at 4°C. After overnight circulation at a flow rate of 5 ml h -1 the column was washed with 10 mM Tris-HCl, pH 8.0, and the retained material was eluted with 100 mM glycine HCl, pH 2.5. The fractions were counted for radioactivity using a Packard 2000 CA liquid scintillation analyser and the fractions containing radioactivity were neutralized with 1 M Tris-HCl, pH 8.0, concentrated by Amicon filtration and subjected to exclusion chromatography on a Sephadex G-50 column. Non-radioactive PIF was also purified from MAC16 and G361 cells using affinity chromatography.
Animal studies
Female NMRI mice (five per group; average weight 20.6 g) were injected intravenously (i.v.) into the tail vein with PIF (7 µg protein in 100 µl PBS) at 1.5 h intervals over a 6 h period (total of four injections). Control animals received PBS alone. Body weight and food and water intake were monitored and the animals were sacrificed 24 h after the first injection. Each carcass was weighed, placed in an oven at 80°C until constant weight was reached and re-weighed. The total fat content of the carcass was determined by the method of Lundholm et al (1980) . The residue was the nonfat mass. The water content was calculated from the difference between the wet and dry weights.
RESULTS
PIF was isolated from G361 cells by an initial 40% ammonium sulphate ((NH 4 ) 2 SO 4 ) precipitation followed by affinity chromatography using monoclonal antibody specific to PIF (Todorov et al, 1996b) . Western blotting of immunoaffinity purified material gave evidence for a single antigen of M r 24 000 identical to that isolated from the MAC 16 tumour (Figure 1) .
In order to evaluate the number, size and attachment of the oligosaccharide chains to the central polypeptide core in human PIF, G361 cells were metabolically labelled with 35 SO 4 and [6-3 H]-glucosamine, which specifically labels the carbohydrate fraction. Immunoaffinity purification gave a single band of radioactivity containing both radioisotopes. The apparent molecular weight as determined by exclusion chromatography on Sephadex G-50 was 24 000 in comparison with standard proteins (Figure 2A ).
Re-chromatography of this material after overnight digestion with PNGase F produced two bands of radioactivity eluting at positions corresponding to M r 14 000 and 10 000 ( Figure 2B ). Both fragments contained 3 H and 35 S. Digestion of the M r 24 000 material with O-glycosidase followed by re-fractionation on Sephadex G50 showed conversion to three bands of radioactivity corresponding to M r 14 000, 6000 and 4000 ( Figure 2C ). The first two fragments contained both radiolabels, while the third only contained 3 H. To evaluate the biological effectiveness of PIF produced by G361, affinity-purified material was administered i.v. to female NMRI mice and changes in body weight and body composition were determined after 24 h (Table 1) . Animals receiving PIF showed a 6.6% decrease in body weight over 24 h, while PBStreated controls showed a 5% increase in body weight. The difference was highly significant (Table 1 ). There was no difference in food and water consumption between the groups. Body composition analysis showed a significant reduction in the non-fat carcass mass (Table 1) , with no change in water or fat content. This suggests that PIF produced by the G361 cell line is biologically active.
DISCUSSION
Using a monoclonal antibody derived from splenocytes of mice bearing the cachexia-inducing MAC16 tumour we have been able to identify an antigen of M r 24 000, which is immunologically identical both in the MAC16 tumour and in the urine of patients with cachexia and a variety of tumour types (Todorov et al, 1996a) . This antigen is a sulphated glycoprotein ) with a central polypeptide core, the amino acid sequence of which is also identical in both mouse (Todorov et al, 1996a ) and man . Material from both sources caused a rapid loss of body weight in non-tumour-bearing mice by specific depletion of the non-fat carcass mass (Todorov et al, 1996a; Cariuk et al, 1997) .
In the present study material of identical molecular weight to that isolated from the MAC16 tumour has been purified from human melanoma cells, G361, confirming the tumour origin of the human product. This material has also identical immunoreactivity with the mouse monoclonal antibody, which recognizes the carbohydrate chains in the glycoprotein . In addition, the number, size and attachment of the oligosaccharide chains to the peptide core is the same in the G361 product as that isolated from the MAC16 tumour. Incubation of PIF from G361 cells with recombinant protease-free PNGase F, which specifically cleaves the N-acetylglucosamine-asparagine bond of N-linked oligosaccharides (Tarentino et al, 1985) , yielded two fragments of M r 14 000 and 10 000, both of which were sulphated, as previously observed with PIF isolated from the MAC16 tumour . The fragment of M r 10 000 has been attributed to a N-linked oligosaccharide chain, while the fragment of M r 14 000 represents the peptide core and residual oligosaccharide. Treatment of PIF from G361 cells with O-glycosidase, which has stringent specificity for the core structure Gal β1→3 Gal NAc α1-Ser/Thr, yielded a fragment of M r 6000, representing an O-linked sulphoglycan chain ) and a fragment of M r 4000 labelled with 3 H alone, representing the core peptide with some carbohydrate attached. Thus the size and attachment of the oligosaccharide chains in the human PIF is the same as previously reported in the mouse . Production of cachexia by G361 cells in nude mice has previously been attributed to the expression of LIF (Mori et al, 1991) . LIF has been suggested to play a role in the cancer cachexia syndrome through the ability to decrease lipoprotein lipase (LPL) activity (Marshall et al, 1994) . Inhibition of LPL would prevent adipocytes extracting fatty acids from plasma lipoproteins for storage, resulting in a net flux of lipid into the circulation. No mechanism has been proposed for catabolism of skeletal muscle by LIF. Inhibition of LPL alone would not produce cachexia, since none is seen in type 1 hyperlipidaemia caused by an inherited deficiency of LPL. Although exogenously administered, recombinant LIF has been shown to induce loss of body weight in experimental animals, this has been reported as only occurring at dose levels near the toxic limit (Metcalf et al, 1990) . The loss of body weight was ascribable to a complete loss of subcutaneous and intra-abdominal fat with no change in liver and kidney weights, suggesting that the weight loss was not a true cachexia. This suggests that factors other than LIF may be responsible for the cachexia induced by G361 cells.
In this study we have shown that PIF, purified from G361 cells, is capable of producing loss of body weight in mice, with specific loss of the carcass non-fat mass. There was no loss of adipose tissue and no decrease in food intake as would be expected with LIF. Thus it is likely that G361 melanoma cells produce cachexia as a result of expression of PIF rather than LIF.
This study has shown that human melanoma cells produce a PIF which is structurally and functionally identical with the mouse factor. Further studies are required to establish the degree of homology of the gene coding for the central polypeptide chain in the two species.
